Dyax Corp. (NASDAQ:DYAX)

Test tubes

5 BioPharma Movers That Cannot Be Ignored

Last week, a few biotech companies made absolutely massive runs, but some had serious falls. In the past year, the health care sector was on fire from positive trials, U.S. ...
Read Full Story »
Pills and tablets

Dyax Agrees to $5.9 Billion Buyout

U.K.-based drugmaker Shire PLC (NASDAQ: SHPG) and Dyax Corp. (NASDAQ: DYAX) announced Monday morning that former will acquire latter for $37.30 in cash per share of Dyax for a total ...
Read Full Story »
Stock Quotes

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

Now that there has been a biotech bloodbath seen of late, many fundamental and technical analysts have been looking for stocks that either are grossly oversold or are now greatly ...
Read Full Story »
generic drugs

Dyax Wins Positive Opinion for European Orphan Designation

Despite taking a slight hit from the collapse within the health care sector in the past quarter, Dyax Corp. (NASDAQ: DYAX) is still up significantly over the past year and ...
Read Full Story »
Sell Button

Key Insider Selling in Aquinox, GoPro, Dyax, F5 and More

The dog days of August have typically meant slow volumes and vacations for the legions of traders and financial professionals that work on Wall Street. It also usually means that ...
Read Full Story »
health care

What FDA Breakthrough Therapy Designation Means for Dyax

Dyax Corp. (NASDAQ: DYAX) announced on Tuesday that the U.S. Food and Drug Administration (FDA) has granted a key breakthrough therapy designation for the investigation of DX-2930 for hereditary angioedema ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: AOL, Cisco, Etsy, GoDaddy, MannKind, Virtu, Caterpillar, Nokia and More

Stocks were up very slightly Monday morning, on the heels of a rate cut in China and after a strong week before. While stocks are close top all-time highs, the ...
Read Full Story »

Dyax Shares Defy Gravity on Secondary Offering News

The newest hot stock in biotechnology is now giving everyone the chance to get a piece of it. Dyax Corp. (NASDAQ: DYAX) announced that it will have an offering of ...
Read Full Story »
thumbs up

Analysts Massively Increasing Dyax Price Targets

The next hot biotech stock could very well be Dyax Corp. (NASDAQ: DYAX). With biotech such a hot sector of late, investors are likely to pay close attention to this ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Alibaba, Altera, Dyax, HP, Kinder Morgan, Kors, Staples, Twitter and More

Stocks were indicated lower on Wednesday, an April Fool's trick for the first day of the quarter. Still, the bull market is six years old as the Dow Jones Industrial ...
Read Full Story »
health care

Why Dyax Will Dominate Biotech News on Wednesday

Dyax Corp. (NASDAQ: DYAX) is almost certain to dominate the biotech news flow on Wednesday. The company announced positive data on Tuesday evening from the Phase 1b clinical study of the ...
Read Full Story »
Wall St Bull statue

Merrill Lynch Makes Changes to SMID-Cap Alpha List for Q2

Since bottoming out back in October, the Russell 2000 has been on fire, and many investors have rotated portfolio allocations back to the index. Typically the small and mid-cap stocks ...
Read Full Story »
Biotechnology word cloud

RBC Has 4 Biotech Stocks to Buy After Massive Pullback

The XBI, which is the S&P 500 biotech index, has been hit hard this week and is down almost 14% since last Friday. While still up big over the past ...
Read Full Story »

Merrill Lynch Has 5 Stocks to Buy With Big Upcoming Catalysts

Two things are often the key to moving a stock price. One is obviously earnings, but a second and equally important is a company with a big upcoming catalyst. A ...
Read Full Story »
health care

Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings

Many investors want to try to find the stocks that are going to offer the traditional “beat and raise estimates” before they release quarterly earnings reports. Actually, it has always ...
Read Full Story »